Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL552292 | 0.96 | GPR84 (0.36) | GPR84 | |
| SCHEMBL552640 | 0.93 | GPR84 (0.35) | GPR84 | |
| SCHEMBL553914 | 0.91 | GPR84 (0.31) | GPR84 | |
| SCHEMBL553552 | 0.90 | GPR84 (0.30) | GPR84 | |
| SCHEMBL553024 | 0.89 | GPR84 (0.33) | GPR84 | |
| SCHEMBL553424 | 0.89 | GPR84 (0.37) | GPR84 | |
| SCHEMBL552713 | 0.89 | — | — | |
| SCHEMBL15282144 | 0.88 | — | — | |
| SCHEMBL553377 | 0.87 | GPR84 (0.31) | GPR84 | |
| SCHEMBL553698 | 0.86 | GPR84 (0.32) | GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9018387-B2 | Complexes of imidazole ligands | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-04-28 | — | — | US | disclosed |
| US-20140242795-A1 | Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-08-28 | — | — | US | disclosed |
| US-8703103-B2 | Volatile imidazoles and group 2 imidazole based metal precursors | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-04-22 | — | — | US | disclosed |
| US-8680289-B2 | Complexes of imidazole ligands | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-03-25 | — | — | US | disclosed |
| US-20130260025-A1 | Group 2 Imidazolate Formulations for Direct Liquid Injection | VERSUM MATERIALS US, LLC | 2013-10-03 | — | — | US | disclosed |
| EP-2644284-A1 | Group 2 Imidazolate Formulations for Direct Liquid Injection | Air Products and Chemicals, Inc. (US) | 2013-10-02 | — | — | EP | disclosed |
| EP-2580223-A1 | COMPLEXES OF IMIDAZOLE LIGANDS | Air Products and Chemicals, Inc. (US) | 2013-04-17 | — | — | EP | disclosed |
| US-20130078391-A1 | Complexes Of Imidazole Ligands | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2013-03-28 | — | — | US | disclosed |
| US-20120121806-A1 | Complexes Of Imidazole Ligands | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| US-20120035351-A1 | Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2012-02-09 | — | — | US | disclosed |
| WO-2011156699-A1 | COMPLEXES OF IMIDAZOLE LIGANDS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2011-12-15 | — | — | WO | disclosed |
| EP-2371821-A1 | Volatile imidazoles and group 2 imidazole based metal precursors | Air Products and Chemicals, Inc. (US) | 2011-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130078391-A1 | Complexes Of Imidazole Ligands | ICOSLG, CLTC, PICALM | GPR84 4655/4885 |
| US-20120035351-A1 | Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors | CACNG5, BST2, API5 | GPR84 3428/4885 |
| US-20120121806-A1 | Complexes Of Imidazole Ligands | ICOSLG, CLTC, PICALM | GPR84 4655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.